Fundraising FoxNectinTx
3 known investors
Find your way into NectinTx
Sign up to see every warm intro you have to NectinTx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NectinTx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms. The company is a biotech firm with a pipeline focused on oncology immunotherapy, including its lead candidate NTX1088 currently in clinical trials.
Investors · 3
Frequently asked questions
- What does NectinTx do?
- Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms. The company is a biotech firm with a pipeline focused on oncology immunotherapy, including its lead candidate NTX1088 currently in clinical trials.
- Who are NectinTx's investors?
- NectinTx's investors include Peregrine Ventures, Cancer Focus, Israel Biotech Fund.